Overview
Benign arteriolar nephrosclerosis is a form of chronic kidney disease characterized by structural changes in the kidney, including glomerulosclerosis and tubulointerstitial damage, primarily due to prolonged hypertension 1.Diagnosis
Elevated blood pressure history
Renal biopsy showing glomerulosclerosis and increased tubulointerstitial fibrosis
Increased immunostaining for type III and type IV collagens in the expanded interstitium on kidney biopsy 1Management
Blood Pressure Control: Aggressive management with antihypertensive medications to target BP <130/80 mmHg 1
Angiotensin-Converting Enzyme Inhibitors (ACEi) or Angiotensin Receptor Blockers (ARBs): Recommended for their renoprotective effects 1
Lifestyle Modifications: Dietary sodium restriction, weight management, and smoking cessation 1Special Populations
Elderly: Focus on careful blood pressure control and renal function monitoring due to increased risk of comorbidities 1Key Recommendations
Regular monitoring of blood pressure and renal function is essential for early detection and management of tubulointerstitial damage 1 (Evidence: Moderate)
Use of ACE inhibitors or ARBs is recommended to mitigate progressive kidney damage 1 (Evidence: Moderate)
Intensive blood pressure control is crucial in managing benign arteriolar nephrosclerosis to slow disease progression 1 (Evidence: Moderate)References
1 Razzaque MS, Cheng M, Horita Y, Nishihara M, Harada T, Taguchi T. Immunohistochemical analysis of type III and IV collagens in tubulointerstitial damage in human benign nephrosclerosis. The Journal of international medical research 1995. link